| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. | General Counsel | Common Stock | 12,138 | $5,242,887 | $431.94 | 06 Mar 2026 | Direct |
| MADRIGAL PHARMACEUTICALS, INC. | General Counsel | Stock Option (Right to Buy) | 5,022 | 04 Mar 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | 04 Mar 2026 | 3 | -$155,498 | 4 | General Counsel | 06 Mar 2026, 18:34 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | 20 Jan 2026 | 2 | -$344,173 | 4 | General Counsel | 20 Jan 2026, 17:58 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | 18 Aug 2025 | 8 | -$479,627 | 4 | General Counsel | 18 Aug 2025, 17:33 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | 05 Mar 2025 | 2 | $0 | 4 | General Counsel | 07 Mar 2025, 16:50 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | 03 Mar 2025 | 1 | -$139,025 | 4 | General Counsel | 05 Mar 2025, 16:36 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | 17 Jan 2025 | 1 | -$75,735 | 4 | General Counsel | 17 Jan 2025, 19:10 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | 15 Aug 2024 | 2 | $0 | 4 | General Counsel | 19 Aug 2024, 20:16 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | 05 Aug 2024 | 0 | $0 | 3 | General Counsel | 15 Aug 2024, 19:52 |